Cargando…

Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells

BACKGROUND: With fast rising incidence, papillary thyroid carcinoma (PTC) is the most common head and neck cancer. Parthenolide, isolated from traditional Chinese medicine, inhibits various cancer cells, including PTC cells. The aim was to investigate the lipid profile and lipid changes of PTC cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Le-Tian, Li, Tie-Jun, Li, Ming-Lin, Luo, Han-Yong, Wang, Yi-Bing, Wang, Jia-He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123985/ https://www.ncbi.nlm.nih.gov/pubmed/37095470 http://dx.doi.org/10.1186/s12906-023-03944-7

Ejemplares similares

Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis
por: Cui, Meng, et al.
Publicado: (2022)

Potential Mechanism of S. baicalensis on Lipid Metabolism Explored via Network Pharmacology and Untargeted Lipidomics
por: Ge, Ping-Yuan, et al.
Publicado: (2021)

The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
por: Yi, Jiaoyu, et al.
Publicado: (2021)

Plasma Lipidomics Profiling Reveals Biomarkers for Papillary Thyroid Cancer Diagnosis
por: Jiang, Nan, et al.
Publicado: (2021)

Parthenolide: a novel pharmacological approach to promote nerve regeneration
por: Diekmann, Heike, et al.
Publicado: (2016)

Volumetric Absorptive Microsampling of Blood for Untargeted Lipidomics
por: Marasca, Camilla, et al.
Publicado: (2021)

Untargeted Lipidomics Reveals Characteristic Biomarkers in Patients with Ankylosing Spondylitis Disease
por: Li, Zhengjun, et al.
Publicado: (2022)

Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma
por: Wang, Zipeng, et al.
Publicado: (2023)

Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics
por: Ismail, Israa T, et al.
Publicado: (2019)

The Hitchhiker’s Guide to Untargeted Lipidomics Analysis: Practical Guidelines
por: Smirnov, Dmitrii, et al.
Publicado: (2021)

Untargeted Lipidomics of Erythrocytes under Simulated Microgravity Conditions
por: Manis, Cristina, et al.
Publicado: (2023)

Untargeted Lipidomics Study of Bipolar Disorder Patients in Serbia
por: Jadranin, Milka, et al.
Publicado: (2023)

Untargeted Lipidomic Profiling of Dry Blood Spots Using SFC-HRMS
por: Le Faouder, Pauline, et al.
Publicado: (2021)

Revealing Further Insights on Chilling Injury of Postharvest Bananas by Untargeted Lipidomics
por: Liu, Juan, et al.
Publicado: (2020)

Comprehensive analysis of untargeted metabolomics and lipidomics in girls with central precocious puberty
por: Zhao, Hong-Ying, et al.
Publicado: (2023)

Untargeted Plasma Lipidomics Reveal Perturbed Metabolites of Glycerophospholipids, and Sphingolipids in Moderate-to-Severe Acne
por: Zhang, Deng, et al.
Publicado: (2023)

To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments
por: Sun, Ying, et al.
Publicado: (2022)

Untargeted lipidomic features associated with colorectal cancer in a prospective cohort
por: Perttula, Kelsi, et al.
Publicado: (2018)

Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles
por: Havranek, Katherine E., et al.
Publicado: (2021)

Untargeted and Targeted Blood Lipidomic Signature Profile of Gestational Alcohol Exposure
por: Naik, Vishal D., et al.
Publicado: (2023)

Integrative processing of untargeted metabolomic and lipidomic data using MultiABLER
por: Lee, Ian C.H., et al.
Publicado: (2023)

Short-Term Stability of Serum and Liver Extracts for Untargeted Metabolomics and Lipidomics
por: Hricko, Jiri, et al.
Publicado: (2023)

Evaluation of Lipid Extraction Protocols for Untargeted Analysis of Mouse Tissue Lipidome
por: Omar, Ashraf M., et al.
Publicado: (2023)

An Untargeted Lipidomics Study of Acute Ischemic Stroke with Hyperglycemia Based on Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry
por: Guo, Jia, et al.
Publicado: (2022)

UHPLC-HRMS-Based Untargeted Lipidomics Reveal Mechanism of Antifungal Activity of Carvacrol against Aspergillus flavus
por: Qu, Chenling, et al.
Publicado: (2021)

Untargeted Mass Spectrometry Lipidomics identifies correlation between serum sphingomyelins and plasma cholesterol
por: Zalloua, Pierre, et al.
Publicado: (2019)

Untargeted lipidomics and metagenomics reveal the mechanism of aspirin eugenol ester relieving hyperlipidemia in ApoE−/− mice
por: Lu, Xiao-Rong, et al.
Publicado: (2022)

Discovery of Biomarkers and Potential Mechanisms of Agarwood Incense Smoke Intervention by Untargeted Metabolomics and Network Pharmacology
por: Dong, Meiyue, et al.
Publicado: (2022)

Cross-Platform Comparison of Untargeted and Targeted Lipidomics Approaches on Aging Mouse Plasma
por: Contrepois, Kévin, et al.
Publicado: (2018)

LC/MS-based untargeted lipidomics reveals lipid signatures of nonpuerperal mastitis
por: Chen, Xiaoxiao, et al.
Publicado: (2023)

Investigating the Potential of Lipids for Use as Biomarkers for Glioblastoma via an Untargeted Lipidomics Approach
por: Soylemez, Burcak, et al.
Publicado: (2023)

Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis
por: Liu, Weifeng, et al.
Publicado: (2017)

Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma
por: Zhu, Yifan, et al.
Publicado: (2021)

First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor
por: Liu, Wenjing, et al.
Publicado: (2022)

The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
por: An, Tao, et al.
Publicado: (2022)

Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF
por: Tian, Bo, et al.
Publicado: (2020)

Ion mobility mass spectrometry enhances low-abundance species detection in untargeted lipidomics
por: Basit, Abdul, et al.
Publicado: (2016)

HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease
por: Zhi, Yixiao, et al.
Publicado: (2021)

Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma
por: Zhou, Hailin, et al.
Publicado: (2022)

Untargeted lipidomic analysis of plasma from obese women submitted to combined physical exercise
por: San Martin, Rocio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0q9733264v486her5sucdl2no9